PROCTER & GAMBLE HEALTH | VIMTA LABS | PROCTER & GAMBLE HEALTH/ VIMTA LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 29.1 | 119.0% | View Chart |
P/BV | x | 10.6 | 4.4 | 241.8% | View Chart |
Dividend Yield | % | 2.0 | 0.4 | 545.3% |
PROCTER & GAMBLE HEALTH VIMTA LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
VIMTA LABS Mar-23 |
PROCTER & GAMBLE HEALTH/ VIMTA LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 540 | 993.6% | |
Low | Rs | 3,883 | 289 | 1,344.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 143.8 | 515.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | 21.8 | 635.0% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 35.6 | 435.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 0.5 | 425.7% | |
Book value per share (Unadj.) | Rs | 447.6 | 124.5 | 359.7% | |
Shares outstanding (eoy) | m | 16.60 | 22.13 | 75.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.9 | 216.6% | |
Avg P/E ratio | x | 33.5 | 19.0 | 175.7% | |
P/CF ratio (eoy) | x | 29.8 | 11.6 | 256.3% | |
Price / Book Value ratio | x | 10.3 | 3.3 | 310.2% | |
Dividend payout | % | 68.7 | 9.2 | 748.0% | |
Avg Mkt Cap | Rs m | 76,761 | 9,171 | 837.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 863 | 238.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,182 | 386.4% | |
Other income | Rs m | 184 | 34 | 534.0% | |
Total revenues | Rs m | 12,480 | 3,216 | 388.0% | |
Gross profit | Rs m | 3,247 | 949 | 342.1% | |
Depreciation | Rs m | 281 | 307 | 91.5% | |
Interest | Rs m | 8 | 26 | 29.1% | |
Profit before tax | Rs m | 3,142 | 650 | 483.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 168 | 503.6% | |
Profit after tax | Rs m | 2,295 | 482 | 476.4% | |
Gross profit margin | % | 26.4 | 29.8 | 88.5% | |
Effective tax rate | % | 27.0 | 25.9 | 104.2% | |
Net profit margin | % | 18.7 | 15.1 | 123.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,637 | 715.7% | |
Current liabilities | Rs m | 6,791 | 573 | 1,185.6% | |
Net working cap to sales | % | 40.0 | 33.4 | 119.7% | |
Current ratio | x | 1.7 | 2.9 | 60.4% | |
Inventory Days | Days | 263 | 8 | 3,158.3% | |
Debtors Days | Days | 343 | 92 | 374.3% | |
Net fixed assets | Rs m | 10,617 | 1,944 | 546.3% | |
Share capital | Rs m | 166 | 44 | 375.1% | |
"Free" reserves | Rs m | 7,265 | 2,710 | 268.1% | |
Net worth | Rs m | 7,431 | 2,754 | 269.8% | |
Long term debt | Rs m | 0 | 99 | 0.0% | |
Total assets | Rs m | 22,330 | 3,580 | 623.7% | |
Interest coverage | x | 409.1 | 25.6 | 1,599.5% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.9 | 62.0% | |
Return on assets | % | 10.3 | 14.2 | 72.6% | |
Return on equity | % | 30.9 | 17.5 | 176.6% | |
Return on capital | % | 42.4 | 23.7 | 178.8% | |
Exports to sales | % | 0 | 26.9 | 0.0% | |
Imports to sales | % | 13.1 | 6.0 | 218.1% | |
Exports (fob) | Rs m | NA | 855 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 190 | 843.0% | |
Fx inflow | Rs m | 1,465 | 855 | 171.4% | |
Fx outflow | Rs m | 1,605 | 190 | 843.0% | |
Net fx | Rs m | -140 | 664 | -21.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 879 | 268.4% | |
From Investments | Rs m | -215 | -573 | 37.6% | |
From Financial Activity | Rs m | -985 | -110 | 896.7% | |
Net Cashflow | Rs m | 1,160 | 197 | 589.0% |
Indian Promoters | % | 0.0 | 36.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 6.6 | 301.2% | |
FIIs | % | 6.2 | 5.1 | 121.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 63.1 | 76.4% | |
Shareholders | 56,778 | 18,550 | 306.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | VIMTA LABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -2.93% | 0.45% |
1-Month | -1.15% | 22.52% | 2.55% |
1-Year | 0.73% | 41.02% | 56.14% |
3-Year CAGR | -8.76% | 30.63% | 15.22% |
5-Year CAGR | 4.97% | 23.01% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the VIMTA LABS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of VIMTA LABS the stake stands at 36.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of VIMTA LABS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
VIMTA LABS paid Rs 2.0, and its dividend payout ratio stood at 9.2%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of VIMTA LABS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.